Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6439 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Examination Marshal Recruitment

New Governance, Risk & Compliance Hub is live

UNIQ+ Postgraduate Research Internships 2024 - Project requests

The UNIQ+ Postgraduate Research Internships programme is seeking project requests from research staff who are willing to supervise interns working in their department during the 2024 summer vacation.

Oxford researchers develop 3D printing method that shows promise for repairing brain injuries

A breakthrough technique developed by University of Oxford researchers could one day provide tailored repairs for those who suffer brain injuries. The researchers demonstrated for the first time that neural cells can be 3D printed to mimic the architecture of the cerebral cortex. These results have been published today in the journal Nature Communications.

The long road to a new malaria vaccine, told by the scientists behind the breakthrough – podcast

Long COVID patients are much more likely to have multiple organ abnormalities

Bones play an important role in our health – here’s how to keep them strong

Oxford-Harrington Rare Disease Centre launches pioneering Therapeutics Accelerator to advance inovative treatments for rare diseases

The University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio announced the launch of the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator with an official signing event at the University of Oxford. The event was hosted by the Oxford-Harrington Rare Disease Centre (OHC), a partnership established in 2019 between the University of Oxford and Harrington Discovery Institute. Attendance at the signing included leaders from OHC, the University of Oxford, the Harrington family, University Hospitals, and Oxford Science Enterprises.

New research endoscopy service launches today

The launch of a new endoscopy service at the Oxford Experimental Medicine Clinical Research Facility (EMCRF) will enhance the collection of data for research projects at the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) and across the University of Oxford.

Oxford R21/Matrix-M™ malaria vaccine receives WHO recommendation for use paving the way for global roll-out

The highly effective vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant is critical to reducing over half a million malaria-related deaths annually.

Have your say - Wellcome Inclusive Well-being Project

New target identified for pancreatic cancer treatment

Researchers at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have found a protein to block the growth of cancer stem-like cells as a possible treatment for pancreatic cancer.

Longer-term organ abnormalities confirmed in some post-hospitalised COVID patients

A study looking at the longer-term impact of COVID-19 has found that nearly a third of patients displayed abnormalities in multiple organs five months after infection, some of which have been shown through previous work to be evidence of tissue damage.

Young people’s mental health deteriorated at greater rate during the pandemic

Young people’s mental health deteriorated during COVID-19, with higher levels of depression and social, emotional and behavioural difficulties than before the pandemic hit, a comprehensive new study has shown.

Evidence shows COVID-19 triggers sustained inflammatory gene expression

In a study, recently published in Genomics Medicine, researchers from NDM’s Wellcome Centre for Human Genetics and the CAMS Oxford Institute investigated the long-term impact of COVID-19 on immune cells.

Oxford ranked third most intensive science and innovation cluster in the world

The index establishes clusters through analysis of patent-filing activity and scientific article publication, documenting the geographical areas around the world with the highest density of inventors and scientific authors. This data forms part of the latest GII, which is due to be published in full later this month (Sept 27).

Study shows detrimental impact of Long Covid on the education and lives of children and young people

New research from the Nuffield Department of Primary Care Health Sciences at the University of Oxford, and the universities of Stirling and Aberdeen funded by the National Institute for Health and Care Research (NIHR), has shone a spotlight on the profound effect Long Covid can have on children and young people’s school experience and wider lives.

Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)

The UK trial is the next step in the development of a vaccine to protect people against MERS – a deadly viral illness with no current vaccines and the potential to cause a pandemic.

When it comes to starting a family, timing is everything

The review, conducted jointly with researchers from Oxford University, the Royal Berkshire Hospital in Reading, and the Princess Anne Hospital in Southampton, included seven randomised controlled trials involving 2,464 women or couples who had been trying to conceive.

Continuing inequalities contribute to wide variation in rates of stillbirths and neonatal deaths across UK

The MBRRACE-UK Collaboration, jointly led by Nuffield Department of Population Health’s National Perinatal Epidemiology Unit (NPEU) and the University of Leicester’s The Infant Mortality and Morbidity Studies (TIMMS) research group, has published a ‘State of the Nation’ report on perinatal deaths in babies born in the UK in 2021.

Load More